1. Adrenalitis and anasarca in idiopathic multicentric Castleman's disease. Issue 10286 (8th May 2021) Authors: Chen, Luke Y C; Skinnider, Brian F; Wilson, Don; Fajgenbaum, David C Journal: Lancet Issue: Volume 397:Issue 10286(2021) Page Start: 1749 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Comment on: HHV-8-negative multicentric Castleman disease patients with serological, histopathological and imaging features of IgG4-related disease: reply. (30th November 2020) Authors: Kawano, Mitsuhiro; Sato, Yasuharu; Fajgenbaum, David C Journal: Rheumatology Issue: Volume 60:Number 2(2021) Page Start: e76 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Commentary on A Case of Rapid Deterioration with Marked Hypergammaglobulinemia. (28th October 2020) Authors: Fajgenbaum, David C; Phillips, Alexis D Journal: Clinical chemistry Issue: Volume 66:Number 11(2020) Page Start: 1378 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. HHV-8-negative multicentric Castleman disease patients with serological, histopathological and imaging features of IgG4-related disease. (9th August 2020) Authors: Kawano, Mitsuhiro; Hara, Satoshi; Yachie, Akihiro; Inoue, Dai; Sato, Yasuharu; Fajgenbaum, David C Journal: Rheumatology Issue: Volume 60:Number 1(2021) Page Start: e3 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Idiopathic multicentric Castleman disease with arteriolar endotheliopathy and secondary haemophagocytosis. Issue 7 (July 2022) Authors: Campbell, Christine M; Owen, Daniel R; Montazeripouragha, Amanallah; McCormick, Iain; Fajgenbaum, David C; Chen, Luke Y C Journal: Lancet Issue: Volume 9:Issue 7(2022) Page Start: e546 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Idiopathic multicentric Castleman's disease: a systematic literature review. Issue 4 (April 2016) Authors: Liu, Amy Y; Nabel, Christopher S; Finkelman, Brian S; Ruth, Jason R; Kurzrock, Razelle; van Rhee, Frits; Krymskaya, Vera P; Kelleher, Dermot; Rubenstein, Arthur H; Fajgenbaum, David C Journal: Lancet Issue: Volume 3:Issue 4(2016) Page Start: e163 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Siltuximab: a targeted therapy for idiopathic multicentric Castleman disease. (January 2016) Authors: Fajgenbaum, David C; Kurzrock, Razelle Journal: Immunotherapy Issue: Volume 8:Number 1(2016:Jan.) Page Start: 17 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. The collaborative network approach: a new framework to accelerate Castleman's disease and other rare disease research. Issue 4 (April 2016) Authors: Fajgenbaum, David C; Ruth, Jason R; Kelleher, Dermot; Rubenstein, Arthur H Journal: Lancet Issue: Volume 3:Issue 4(2016) Page Start: e150 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. We get it : voices of grieving college students and young adults /: voices of grieving college students and young adults. (2015) Authors: Servaty-Seib, Heather L (Heather Lynn); Fajgenbaum, David C Record Type: Book Extent: 1 online resource View Content: Available online (eLD content is only available in our Reading Rooms) ↗